News

Harvard Law School Makes Online Zero-L Course Free for All U.S. Law Schools Due to Coronavirus

News

For Kennedy School Fellows, Epstein-Linked Donors Present a Moral Dilemma

News

Tenants Grapple with High Rents and Local Turnover at Asana-Owned Properties

News

In April, Theft Surged as Cambridge Residents Stayed at Home

News

The History of Harvard's Commencement, Explained

LETTERS ON PSILOCYBIN

NO WRITER ATTRIBUTED

To the Editors of the CRIMSON:

There is a factual misstatement which appeared in an article on Thursday, March 15, that I should like to correct. You stated "Alpert also asserted that the Food and Drug Administration. The University Health Services, and the synthesizer of psilocybin have approved the experiments." I did not say that and it is not true. None of these organization are set up to pass judgment on research. What I did say was (1) the Food and Drug Administration knows of our work and a discussion with them brought to light no illegality in our research activities, (2) the University Health Services were kindly providing screening and on-call medical service for our research, and (3) that the pharmaceutical company knew of our work and was providing the materials for it.

I wish to make these corrections in order that the function of these agencies in no way be misinterpreted by your readers. Thank you. Richard Alpert,   Assistant Professor,   Clinical Psychology.

Want to keep up with breaking news? Subscribe to our email newsletter.

Tags